scispace - formally typeset
M

Maikel P. Peppelenbosch

Researcher at Erasmus University Rotterdam

Publications -  610
Citations -  25498

Maikel P. Peppelenbosch is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Signal transduction & Cancer. The author has an hindex of 74, co-authored 565 publications receiving 21791 citations. Previous affiliations of Maikel P. Peppelenbosch include University of Amsterdam & University Medical Center Groningen.

Papers
More filters
Journal ArticleDOI

The coagulation factor Xa/protease activated receptor-2 axis in the progression of liver fibrosis: a multifaceted paradigm

TL;DR: This work has shown that FXa triggers fibroproliferative and pro‐inflammatory responses in mesenchymal cells and modulates the survival of epithelial cells via PAR‐2 activation, and that targeting FXa in animal models of liver fibrosis results in positive results.
Journal ArticleDOI

Genetically Modified Lactococcus lactis for Delivery of Human Interleukin-10 to Dendritic Cells.

TL;DR: The spatially restricted delivery of IL-10 by food-grade bacteria is a promising strategy to induce suppressor Th-cells in vivo and to treat inflammatory diseases.
Journal ArticleDOI

Modeling liver cancer and therapy responsiveness using organoids derived from primary mouse liver tumors.

TL;DR: Interestingly, single cells from the tumor organoids have high efficiency of organoid initiation, and a single organoid derived from a cancer cell is able to initiate a tumor in mice, indicating the enrichment of tumor-initiating cells in the tumororganoids.
Journal ArticleDOI

Coagulation factor Xa drives tumor cells into apoptosis through BH3-only protein Bim up-regulation.

TL;DR: In this article, it was shown that coagulation factor (F)Xa can drive tumor cells of epithelial origin, but not endothelial cells or monocytes, into apoptosis, whereas it even enhances fibroblast survival.